120 related articles for article (PubMed ID: 22806713)
1. Response to a single dose of sildenafil in single-ventricle patients: an echocardiographic evaluation.
Jackson KW; Butts RJ; Svenson AJ; McQuinn TC; Atz AM
Pediatr Cardiol; 2013 Oct; 34(7):1739-42. PubMed ID: 22806713
[TBL] [Abstract][Full Text] [Related]
2. Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation.
Goldberg DJ; French B; Szwast AL; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
Pediatr Cardiol; 2012 Jun; 33(5):689-96. PubMed ID: 22331056
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.
Hill KD; Tunks RD; Barker PC; Benjamin DK; Cohen-Wolkowiez M; Fleming GA; Laughon M; Li JS
Pediatr Crit Care Med; 2013 Jul; 14(6):593-600. PubMed ID: 23823195
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil improves exercise hemodynamics in Fontan patients.
Van De Bruaene A; La Gerche A; Claessen G; De Meester P; Devroe S; Gillijns H; Bogaert J; Claus P; Heidbuchel H; Gewillig M; Budts W
Circ Cardiovasc Imaging; 2014 Mar; 7(2):265-73. PubMed ID: 24478333
[TBL] [Abstract][Full Text] [Related]
7. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness of oral sildenafil versus oxygen administration as a test for feasibility of operation for patients with secondary pulmonary arterial hypertension.
Ajami GH; Borzoee M; Radvar M; Amoozgar H
Pediatr Cardiol; 2008 May; 29(3):552-5. PubMed ID: 18058160
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous sildenafil in children with palliated single ventricle heart defects: effect of elevated hepatic pressures.
Hill KD; Sampson MR; Li JS; Tunks RD; Schulman SR; Cohen-Wolkowiez M
Cardiol Young; 2016 Feb; 26(2):354-62. PubMed ID: 26197839
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil and ventriculo-arterial coupling in Fontan-palliated patients: a noninvasive echocardiographic assessment.
Shabanian R; Shahbaznejad L; Razaghian A; Kiani A; Rahimzadeh M; Seifirad S; Kocharian A; Gilani JS; Navabi MA
Pediatr Cardiol; 2013 Jan; 34(1):129-34. PubMed ID: 22864675
[TBL] [Abstract][Full Text] [Related]
11. Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.
Buvat J; Büttner H; Hatzimouratidis K; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
J Sex Med; 2013 Jun; 10(6):1592-602. PubMed ID: 23551622
[TBL] [Abstract][Full Text] [Related]
12. eComment. Further study needed.
Quraishi NN; Lemon TI; Black LF
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):968. PubMed ID: 24243943
[No Abstract] [Full Text] [Related]
13. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
Garg N; Sharma MK; Sinha N
Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease.
Clavé MM; Maeda NY; Thomaz AM; Bydlowski SP; Lopes AA
Congenit Heart Dis; 2019 Mar; 14(2):246-255. PubMed ID: 30343508
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil and diastolic dysfunction after acute myocardial infarction trial: rationale and design.
Andersen MJ; Gustafsson F; Hassager C; Køber L; Møller JE
Clin Cardiol; 2013 Apr; 36(4):179-83. PubMed ID: 23450513
[TBL] [Abstract][Full Text] [Related]
16. How long can we leave patients with pulmonary arterial hypertension on oral drug monotreatment?
Ogawa A; Matsubara H
Circ J; 2012; 76(5):1089-90. PubMed ID: 22466634
[No Abstract] [Full Text] [Related]
17. Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.
Behzadnia N; Najafizadeh K; Sharif-Kashani B; Dameshghi DO; Shahabi P
Heart Vessels; 2010 Jul; 25(4):313-8. PubMed ID: 20676840
[TBL] [Abstract][Full Text] [Related]
18. Reply: To PMID 24837446.
Chen H; Weng Z
Urology; 2014 Jul; 84(1):56. PubMed ID: 24837448
[No Abstract] [Full Text] [Related]
19. Editorial comment.
Hanno P
Urology; 2014 Jul; 84(1):56. PubMed ID: 24837446
[No Abstract] [Full Text] [Related]
20. Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis.
Lindman BR; Zajarias A; Madrazo JA; Shah J; Gage BF; Novak E; Johnson SN; Chakinala MM; Hohn TA; Saghir M; Mann DL
Circulation; 2012 May; 125(19):2353-62. PubMed ID: 22447809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
